fbpx

Iron rim lesions linked to worse disability

Iron rim lesions linked to worse disability Published 04 August 2022 Patients with multiple sclerosis (MS) whose MRI scans show iron rim lesions (IRL) are likely to have more substantial disability, according to a new study. IRLs are regions of chronic nervous system damage with ongoing inflammation. They are often
Read More

Intermittent fasting may benefit MS

Intermittent fasting may benefit MS Published 04 August People with multiple sclerosis (MS) who undertook an eight-week intermittent fasting plan had immune and metabolic changes according to a new small study. Researchers enrolled 36 patients and split them into three groups. In the control diet, patients received 100 per cent
Read More

MS-UK wins third best workplace for women award

MS-UK wins third best workplace for women award MS-UK has just been awarded third place in the 2022 UK’s Best Workplaces for Women out of 263 other ranked organisations. What this means is that MS-UK is a great place to for all, including women. The recognition means it is an
Read More

Proteins which block remyelination in MS discovered

Proteins which block remyelination in MS discoveredPublished 29 June 2022 Proteins called tenascins block the body’s ability for remyelination, a study on mice has revealed. Remyelination – the growing back of the myelin sheath that surrounds the nerves and was damaged by multiple sclerosis (MS) – is considered the holy
Read More

Erectile dysfunction three times more common in MS

Erectile dysfunction three times more common in men with MSPublished 28 June 2022 A recent study has found that erectile dysfunction is around three times more common in men with multiple sclerosis (MS) than in healthy men. Sexual dysfunction affects an estimated 40-80% of female MS patients and 50-90% of
Read More

Large number of immune cells in blood linked to MS

Large number of immune cells in blood linked to MSPublished 22 June 2022 Having a large number of immune cells in the bloodstream may increase a person’s likelihood of getting multiple sclerosis, a new study has found. One type of immune cell in particular, natural killer (NK) cells, was found
Read More

Faecal matter transplants may enrich gut in MS

Faecal matter transplants potential to enrich gut in MS patientsPublished 20 June 2022 Faecal matter transplants have been found to be safe and well-tolerated for people with relapsing remitting multiple sclerosis (MS), according to a new small study. In recent years, the bacteria that live in the gut have come
Read More

Treatment shows remyelination promise

Treatment shows remyelination promisePublished 08 June 2022 A new experimental treatment has been shown to promote the restoration of the myelin sheath in preclinical models of the disease. ABX-002, which is being developed by Autobahn Therapeutics, is a thyromimetic – a lab-made molecule which is designed to mimic the activity
Read More

Low APP levels linked to MS fatigue

Low APP levels linked to MS fatiguePublished 08 June 2022 A new study has found that multiple sclerosis (MS) patients with fatigue have lower levels of amyloid precursor protein (APP) in the cerebrospinal fluid compared with both MS patients without fatigue and healthy people. APP is a molecule involved in
Read More

New trial tests clemastine and metformin for MS

New clinical trial will test diabetes drug and antihistamine for MSPublished 26 April 2022 A new clinical trial is taking place which will test to see if taking diabetes drug metformin, and antihistamine drug clemastine, could be used to help repair myelin in people with multiple sclerosis (MS).   Laboratory
Read More